神州细胞(688520)
 
 
  日线
顶尖财经网欢迎您!
  K线
 
 最新动态
  投资评级

研究机构 评级日期 最新评级 上次评级
国金证券 2024-01-25 买入 买入
开源证券 2023-12-19 买入
  盈利预测
据神州细胞三季报分析:

  盈利能力维持稳定,主营获利能力保持稳定

  成长能力维持稳定,营业收入增速大幅减缓

  偿债能力维持稳定,盈利增速略高于债务增速

  运营能力维持稳定,资金使用效率有所下降

  现金流能力维持稳定,销售回款能力同步增强

  财务数据
    截至第三季度实现净利润-2.20亿元,每股收益-0.49元。

    截至第三季度最新股东权益-43909.87万元,未分配利润-375041.61万元。

    截至第三季度最新总资产284759.54万元,负债328669.40万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入1,379,251,634.17808,075,290.81328,779,509.011,023,176,678.65
营业总成本1,331,517,554.73821,713,792.78388,073,340.711,413,264,307.71
营业利润58,121,539.5317,472,849.68-51,421,839.11-357,678,781.53
利润总额-220,383,751.08-138,112,146.44-153,348,003.27-520,052,611.57
净利润-220,383,751.08-138,112,146.44-153,348,003.27-520,052,611.57
其他综合收益-67,674.3849,648.68--
综合收益总额-220,451,425.46-138,062,497.76-153,348,003.27-520,052,611.57
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计1,207,126,494.61,167,519,220.931,466,332,092.971,531,346,784.11
非流动资产合计1,640,468,868.071,623,343,924.681,411,617,011.571,204,528,824.22
资产总计2,847,595,362.672,790,863,145.62,877,949,104.542,735,875,608.33
流动负债合计2,103,543,720.941,717,774,545.781,574,399,696.031,372,001,689.62
非流动负债合计1,183,150,306.831,438,984,369.871,691,846,142.811,606,064,864.15
负债合计3,286,694,027.773,156,758,915.653,266,245,838.842,978,066,553.77
归属于母公司股东权益合计-433,138,935.2-360,100,841.64-382,420,147.87-236,650,939.28
股东权益合计-439,098,665.1-365,895,770.04-388,296,734.3-242,190,945.44
负债和股东权益合计2,847,595,362.672,790,863,145.62,877,949,104.542,735,875,608.33
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计1,399,193,356.76934,561,601.07367,633,516.251,040,822,985.49
经营活动现金流出小计1,772,871,257.291,109,794,649.45489,625,310.681,468,732,659.98
经营活动产生的现金流量净额-373,677,900.53-175,233,048.38-121,991,794.43-427,909,674.49
投资活动现金流入小计1,036,648,222.34875,492,101.61356,700,806.293,349,320,263.74
投资活动现金流出小计1,449,003,026.781,225,446,888.64874,368,361.273,897,803,034.57
投资活动产生的现金流量净额-412,354,804.44-349,954,787.03-517,667,554.98-548,482,770.83
筹资活动现金流入小计1,358,027,023.53892,614,993.31403,095,198.052,278,381,881.68
筹资活动现金流出小计1,133,756,110.25788,373,083.45189,159,862.84680,411,131.66
筹资活动产生的现金流量净额224,270,913.28104,241,909.86213,935,335.211,597,970,750.02
汇率变动对现金及现金等价物的影响-217,184.8880,285.74-6,118.97-12,118.12
现金及现金等价物净增加额-561,978,976.57-420,865,639.81-425,730,133.17621,566,186.58
期末现金及现金等价物余额409,079,124.06550,192,460.82545,327,967.46971,058,100.63
  主营收入+营业利润
 
  净利润+每股收益
  股东权益+未分配利润
 
  总资产+负债
  投资要点

    截至第三季度实现净利润-2.20亿元,每股收益-0.49元。

    截至第三季度最新股东权益-43909.87万元,未分配利润-375041.61万元。

    截至第三季度最新总资产284759.54万元,负债328669.40万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入1,379,251,634.17808,075,290.81328,779,509.011,023,176,678.65
营业总成本1,331,517,554.73821,713,792.78388,073,340.711,413,264,307.71
营业利润58,121,539.5317,472,849.68-51,421,839.11-357,678,781.53
利润总额-220,383,751.08-138,112,146.44-153,348,003.27-520,052,611.57
净利润-220,383,751.08-138,112,146.44-153,348,003.27-520,052,611.57
其他综合收益-67,674.3849,648.68--
综合收益总额-220,451,425.46-138,062,497.76-153,348,003.27-520,052,611.57
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计1,207,126,494.61,167,519,220.931,466,332,092.971,531,346,784.11
非流动资产合计1,640,468,868.071,623,343,924.681,411,617,011.571,204,528,824.22
资产总计2,847,595,362.672,790,863,145.62,877,949,104.542,735,875,608.33
流动负债合计2,103,543,720.941,717,774,545.781,574,399,696.031,372,001,689.62
非流动负债合计1,183,150,306.831,438,984,369.871,691,846,142.811,606,064,864.15
负债合计3,286,694,027.773,156,758,915.653,266,245,838.842,978,066,553.77
归属于母公司股东权益合计-433,138,935.2-360,100,841.64-382,420,147.87-236,650,939.28
股东权益合计-439,098,665.1-365,895,770.04-388,296,734.3-242,190,945.44
负债和股东权益合计2,847,595,362.672,790,863,145.62,877,949,104.542,735,875,608.33
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计1,399,193,356.76934,561,601.07367,633,516.251,040,822,985.49
经营活动现金流出小计1,772,871,257.291,109,794,649.45489,625,310.681,468,732,659.98
经营活动产生的现金流量净额-373,677,900.53-175,233,048.38-121,991,794.43-427,909,674.49
投资活动现金流入小计1,036,648,222.34875,492,101.61356,700,806.293,349,320,263.74
投资活动现金流出小计1,449,003,026.781,225,446,888.64874,368,361.273,897,803,034.57
投资活动产生的现金流量净额-412,354,804.44-349,954,787.03-517,667,554.98-548,482,770.83
筹资活动现金流入小计1,358,027,023.53892,614,993.31403,095,198.052,278,381,881.68
筹资活动现金流出小计1,133,756,110.25788,373,083.45189,159,862.84680,411,131.66
筹资活动产生的现金流量净额224,270,913.28104,241,909.86213,935,335.211,597,970,750.02
汇率变动对现金及现金等价物的影响-217,184.8880,285.74-6,118.97-12,118.12
现金及现金等价物净增加额-561,978,976.57-420,865,639.81-425,730,133.17621,566,186.58
期末现金及现金等价物余额409,079,124.06550,192,460.82545,327,967.46971,058,100.63
  十大流通股东
十大流通股东 报告期:2023-09-30
股东名称 持股数量(万股) 占总股本比例(%) 上期持股变化(万股)
浙江清松投资管理有限公司-宁波清松稳胜企业管理合伙企业(有限合伙)564.615.68-55.25
上海集桑医疗科技有限公司379.713.820.00
天津盈亚股权投资基金管理有限责任公司-天津盼亚股权投资基金合伙企业(有限合伙)372.153.750.00
周勇275.862.780.00
香港中央结算有限公司242.542.4447.19
华宏强震(天津)企业管理咨询合伙企业(有限合伙)203.312.050.00
中国银行股份有限公司-招商国证生物医药指数分级证券投资基金198.812.00-2.32
QM65 LIMITED157.371.58-132.31
中国对外经济贸易信托有限公司-外贸信托-高毅晓峰鸿远集合资金信托计划148.451.49148.45
上海高毅资产管理合伙企业(有限合伙)-高毅晓峰2号致信基金147.031.48147.03
  主力控盘
  公司简介
神州细胞 所属地域: 北京市 涉及概念: 百度概念,沪股通,创新药,重组蛋白,生物疫苗,生物医药,融资融券
主营业务: 药品生产、药品批发、药品零售、药品进出口(具体经营项目以相关部门批准文件或许可证件为准),一般项目:技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广;医学研究和试验发展;货物进出口;技术进出口;进出口代理。(除依法须经批准的项目外,凭营业执照依法自主开展经营活动)。
上市日期: 2020-06-22 每股净资产: -0.97元 每股收益: -0.49元 净利润: -2.20亿元 净利润增长率: 45.37%
营业收入: 13.79亿元 每股现金流: -0.84元 每股公积金: 6.45元 每股未分配利润: -8.42元 总股本: 4.45亿 流通股: 4.31亿
以上信息为合作方、加盟公司及会员收集,本站不拥有版权,版权归原作者所有,所载文章、数据仅供参考,据此操作,风险自负。

中 华 顶 尖 财 经 -- 中 华 顶 尖 网 络 信 息 服 务 中 心